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1170Objectives: Although a number of reports have identified risk factors for postoperative recurrence of atrial fibril-
lation after the maze procedure, no studies have investigated the influence of postoperative mitral valve disease on
atrial fibrillation recurrence after mitral valvuloplasty combined with the maze procedure.
Methods: Between January 1999 and October 2006, 228 patients underwent the maze procedure and concom-
itant mitral valve repair. There were 4 early deaths. Of the early survivors, 206 patients with restored sinus rhythm
were chosen for analysis. During a median follow-up of 50.8 months (range, 0.6–122.8 months), there were 35
patients who had mitral regurgitation (n ¼ 26) or mitral stenosis (n ¼ 9). Patients who had postoperative mitral
valve disease (disease group, n ¼ 35) were compared with those who did not (control group, n ¼ 171) for late
recurrence of atrial fibrillation.
Results: Twenty-eight patients experienced late recurrence of atrial fibrillation. The disease group had a higher
atrial fibrillation recurrence rate than the control group (5-year atrial fibrillation–free rates were 65.2% 10.3%
and 85.8% 3.4%, respectively; P¼ .014). Univariate and multivariate analyses of a range of variables revealed
that a larger preoperative left atrial size (hazard ratio, 2.61; P ¼ .041), the use of microwave ablation rather than
cryoablation (hazard ratio, 2.33; P ¼ .041), the presence of early (<3 months) postoperative atrial fibrillation
events (hazard ratio, 3.75; P ¼ .001), and the presence of postoperative mitral valve disease (hazard ratio,
3.67; P ¼ .005) were independent predictors for late atrial fibrillation recurrence.
Conclusions:Maze procedure outcomes were negatively affected by postoperative mitral valve disease after mitral
valvuloplasty, as evidenced by greater atrial fibrillation recurrence. (J Thorac Cardiovasc Surg 2010;139:1170-6)The maze operation accompanied by mitral valve (MV)
surgery is regarded as the best option for terminating atrial
fibrillation (AF) in patients with mitral disease and AF.1
However, long-term follow-up of patients who undergo
the maze procedure suggests that late AF recurrence limits
the benefits of the procedure.2-6 Studies investigating
patients at greater risks of AF recurrence revealed that
preoperative conditions, such as longer AF duration, a fine
AF-wave pattern, a larger left atrial (LA) size, older age,
a higher left ventricular mass index, and a higher cardiotho-
racic ratio, were positive predictors of AF recurrence.2-5e Departments of Thoracic and Cardiovascular Surgerya and Preventive
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The Journal of Thoracic and Cardiovascular SurIncreased pressure and volume load to the LA caused by
remnant or recurrent mitral disease after mitral valvuloplasty
can induce LA chamber enlargement. Because these pro-
cesses are regarded as the source of AF generation in patients
with mitral disease in general, patients with postoperative
MV disease are expected to have a greater risk of AF recur-
rence after the maze operation. However, to our knowledge,
no studies have investigated whether remnant or recurrent
MV disease after MV repair is associated with an increased
risk of AF recurrence after the maze operation.
The aim of this study was to investigate the influence of
postoperative MV dysfunction on late AF recurrence after
the maze procedure combined with MV repair. For this,
we performed univariate and multivariate risk factor analy-
ses for recurrent AF after surgical intervention, including
postoperative MV disease as a candidate risk variable.MATERIALS AND METHODS
Patients
From January 1999 to October 2006, 228 patients underwent the maze
procedure combined with MV repair in Asan Medical Center, Seoul, South
Korea. The maze procedure and MV repair were performed concomitantly
with or without other cardiac procedures. There were 4 early deaths. Fifteen
patients did not recover sinus rhythm, and of these patients, 3 underwent
permanent pacemaker insertion. One patient was lost to follow-up. Of the
early survivors, 208 (91.2%) had restored sinus rhythm. Patients weregery c May 2010
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DAbbreviations and Acronyms
AF ¼ atrial fibrillation
CI ¼ confidence interval
HR ¼ hazard ratio
LA ¼ left atrium
MR ¼ mitral regurgitation
MV ¼ mitral valvedivided into 2 groups according to the presence or absence of postoperative
MV disease. Postoperative MV disease was defined as follows: (1) mitral
regurgitation (MR) of greater than grade 2 or (2) mitral stenosis defined
by an MV area of less than 2.0 cm2 or a transmitral peak pressure gradient
of greater than 10 mmHg. There were 37 patients who met these criteria (28
with MR and 9 with mitral stenosis). Two patients in the postoperative MV
dysfunction group underwent reoperation. One patient revealed failed mitral
repair on predischarge echocardiographic analysis and underwent tissue
valve replacement on postoperative day 14. Another patient showed late
MR recurrence caused by chordae rupture and underwent redo mitral repair
(the Alfieri technique) on postoperative day 547. Because these 2 patients do
not represent the true postoperative MV dysfunction group after reopera-
tion, they were excluded from the present study. Finally, 35 patients with
postoperative MV dysfunction were included in this study and were defined
as the disease group.
Those who did not show postoperative MV disease were defined as the
control group (n ¼ 171). The study compared the 2 groups in terms of AF
recurrence, changes in LA size, and transmitral A-wave characteristics.
This study was approved by our institution’s ethics committee/institu-
tional review board.
Surgical Procedures
A median sternotomy approach was used for most patients (n ¼ 169
[82.0%]), and a right anterolateral minithoracotomy approach with the
AESOP 3000 system (Computer Motion, Inc, Santa Barbara, Calif) was
used in the most recent patients (n¼ 37 [18.0%]). Conventional ascending
aorta and bicaval cannulation was used for the sternotomy approach, and the
minimally invasive approach involved peripheral cannulation through the
right internal jugular vein, right femoral vein, and right femoral artery. Myo-
cardial protection was achieved with antegrade and retrograde tepid blood
cardioplegia. After aortic crossclamping, MV exposure was obtained
through an LA incision.
A modification of the maze procedure was performed, the details of
which have been described previously.7 LA size was reduced by means
of generous resection of redundant atrial tissue off the posterior LAwall par-
allel to the posterior mitral annulus. The degree of LA wall resection was
determined based on preoperative LA size, with a target postoperative LA
size of less than 50 mm.
Echocardiography
Two-dimensional echocardiographic analysis and Doppler color-flow
imaging were performed on all patients with a Hewlett–Packard Sonos
2500 or 5500 imaging system equipped with a 2.5-MHz transducer
(Hewlett–Packard, Andover, Mass). Preoperative echocardiographic analy-
sis (both transthoracic and transesophageal) was performed in all patients
within 2 months before the operation. Postoperative transthoracic echocar-
diographic evaluation was performed at 3 and 6months and every year there-
after. Doppler flow mapping was used for semiquantitation of MR; at least
grade 3 MR was defined as a distal regurgitant jet area of greater than 8
cm2 or a radius of proximal flow convergence of greater than 0.5 cm at the
aliasing velocity of 40 cm/s. MV area was estimated by using the pressureThe Journal of Thoracic and Carhalf-time method. LA size was measured based on its anteroposterior diam-
eter on the parasternal long-axis view at end-systole.
Postoperative Rhythm Follow-up
Postoperatively, in-patient rhythms were monitored daily by using
standard 12-channel surface electrocardiographic analysis. Patients were
routinely evaluated with 24-hour Holter monitoring before hospital dis-
charge. Follow-up electrocardiograms were performed at 3- to 6-month
intervals during the first 2 years and every year thereafter. Any symptoms
suspicious of arrhythmia were assessed by means of 24-hour Holter moni-
toring during follow-up. Recurrences or events of AF during the initial post-
ablation blanking period of 3 months are defined as early events. A failure of
the maze procedure defines any recurrent AF, atrial tachycardia, or atrial
flutter at least 3 months after stopping antiarrhythmic agents as beyond
the initial blanking period. The results are presented in ‘‘Freedom from
AF without antiarrhythmic agent.’’ The definitions on early events (initial
blanking period) and a failure of the maze procedure were based on the con-
sensus of reporting standards made by the Heart Rhythm Society Task Force
on Catheter and Surgical Ablation of AF.8
All data were collected prospectively and stored for later assessment in
a specially designed and regimented database.
Postoperative Management
Postoperative AF, atrial flutter, atrial tachycardia, frequent atrial prema-
ture beats, and recurrent atrial tachyarrhythmia were treated with amiodar-
one, which was commenced at 1200 mg/d and tapered according to the
patients’ rhythm status. A rapid ventricular rate despite the amiodarone ther-
apy was controlled with b-blockers or calcium-channel blockers. Patients
were routinely anticoagulated with warfarin for 3 to 6 months postopera-
tively with a target international normalized ratio of 1.5 to 2.5 at the discre-
tion of the attending surgeon. The maintenance of anticoagulation therapy
thereafter was determined according to the individual patient’s risk factors
of thromboembolism and cardiac rhythm status. Postoperative AF or the ab-
sence of effective atrial contraction resulted in anticoagulation therapy that
was continued until both sinus rhythm and atrial contractility were restored.
Statistics
Categorical variables were presented as frequencies and percentages and
were compared by using the c2 or Fisher’s exact tests. Continuous variables
were expressed as means standard deviations or medians with ranges and
were compared by using the Student’s unpaired t test or the Mann–Whitney
U test, as appropriate. Kaplan–Meier curves were used to delineate freedom
from MV disease and freedom from AF, and log-rank tests were used to
compare the differences in AF-free rates between groups. Stratified survival
curves (freedom from AF without an antiarrhythmic agent) were plotted
to explore unadjusted differences for variables of interest. For multivariate
analyses, the updated covariate Cox models were used to examine the asso-
ciation of baseline characteristics with time to AF recurrence.9 Variables
with a P value .20 or less in univariate analyses were candidates for the mul-
tivariable updated covariate Cox models. Multivariate analyses involved
a backward elimination technique, and only variables with a P value of
less than .10 were used in the final model. Results were expressed as hazard
ratios (HRs) with 95% confidence intervals (CIs). All reported P values are
2-sided. SAS software version 9.1 (SAS Institute, Inc, Cary, NC) and SPSS
version 12 were used for the statistical analysis.
RESULTS
Baseline Characteristics
The median age at the time of the operation was 50 years
(range, 18–80 years), and 114 (55.3%) patients were
women. Clinical follow-up was completed with all pa-
tients, with a median follow-up period of 50.8 monthsdiovascular Surgery c Volume 139, Number 5 1171
TABLE 1. Preoperative patient profiles
Control group Disease group P value
No. of patients 171 35
Age (y), median (range) 50 (18–80) 50 (30–69) .838
Female sex (no.) 91 23 .175
Cardiothoracic ratio (%) 58.7  8.4 58.9  11.5 .897
Presence of coronary
disease (no.)
22 4 1.00
Previous cardiac surgery (no.) 5 2 .339
Diagnosis .346
Mitral regurgitation (no.) 126 23
Mitral stenosis (no.) 12 5
Mitral stenoregurgitation (no.) 33 7
Cause of MV disease .058
Degenerative (no.) 81 11 .095
Rheumatic (no.) 77 21 .120
Ischemic (no.) 11 1 .695
Infective (no.) 2 1
Congenital (no.) 0 1
Echocardiographic data
LV ejection fraction (%) 55.3  11.0 55.4  10.2 .961
LA dimension (mm) 60.1  9.7 60.8  8.4 .727
LV end-systolic
diameter (mm)
42.5  8.7 39.7  7.0 .131
LV end-diastolic
diameter (mm)
62.2  9.9 59.2  8.6 .125
AF profiles
AF duration, years,
median (range)
2 (0–25) 3 (0–20) .331
Paroxysmal AF (no.) 21 4 >.999
Fine (<1 mm) AF
wave (no.)
72 14 .985
Data represent means  standard deviations. MV, Mitral valve; LV, left ventricular;
LA, left atrial; AF, atrial fibrillation. Data represent mean (SD).
TABLE 2. Surgical procedures
Control
group
Disease
group
P
value
No. of patients 171 35
Cardiopulmonary bypass time (min) 159.4  43.7 165.4  45.1 .469
Aortic clamping time (min) 114.1  32.3 115.5  31.0 .817
MV procedure
Ring annuloplasty (no.) 156 27 .016*
Commissurotomy (no.) 31 11 .105
Commissural repair (no.) 13 0 .131
Triangular or quadrangular
resection (no.)
24 6 .605
Leaflet mobilization (no.) 26 8 .316
New chordae formation (no.) 40 4 .173
Papillary muscle splitting (no.) 16 9 .019*
Annular plication or sliding
technique (no.)
8 3 .351
Leaflet patch or extension (no.) 9 2 >.999
Chordae transfer (no.) 2 0 >.999
Alfieri technique (no.) 2 2 .135
Cardiac cooperation
Tricuspid valve repair (no.) 62 18 .759
Ring annuloplasty (no.) 41 12
Kay method (no.) 8 1
De Vega method (no.) 13 3
Other cardiac procedures .185
Aortic valve replacement (no.) 15 4
Aortic valve repair (no.) 2 3
Coronary artery bypassing (no.) 14 3
ASD, VSD, PDA (no.) 6 1
Aortic operation (no.) 1 0
Others (no.) 1 0
Minimally invasive approach (no.) 33 4 .339
Alternative energy sources for
the maze procedure (no.)
.879
Cryoablation (no.) 115 24
Microwave ablation (no.) 56 11
MV, Mitral valve; ASD, atrial septal defect; VSD, ventricular septal defect; PDA, patent
ductus arteriosus. *P< .05.
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D(range, 0.6–122.8 months). Acquisition of electrocardio-
grams and echocardiographic data for more than 12 months
postoperatively was possible in 193 (93.6%) patients. The
control and disease groups were similar in terms of preop-
erative demographic characteristics, echocardiographic
profiles, and clinical manifestation of MV disease and
AF (Table 1). LA wall resection was preformed for 186
(90.3%) patients, and both groups had a similar proportion
of patients who underwent the LA reduction procedure (P
¼ .538). Ring annuloplasty was used more frequently in
the control group, whereas the papillary muscle–splitting
technique was used more frequently in the disease group.
The 2 groups were similar in terms of concomitant cardiac
operations (Table 2).
Immediate and Long-Term Clinical Outcomes
There were 3 late strokes and 7 late deaths. The overall
cerebrovascular accident–free survival rate was 96.9% 
1.3% at 5 years. Of the 35 patients in the disease group,
echocardiographic analysis detected postoperative MV1172 The Journal of Thoracic and Cardiovascular Surdisease in 3 before discharge, whereas the remaining 32
were detected during follow-up. In terms of valvulopathy re-
sponse to medical therapy, improvement to regression of
MR of grade 2 or less was observed in 15 patients, and there
was no response or aggravation in the remaining 20 patients.
The overall postoperative MV disease–free rates were
84.1%  2.7% at 3 years and 79.0%  3.4% at 5 years
(Figure 1). Although log-rank–univariate risk factor analysis
identified no use of an annuloplasty ring (P ¼ .031) and use
of the papillary muscle–splitting technique (P ¼ .015) as
risk factors for postoperative MV dysfunction, Cox multi-
variate analysis revealed that none of those factors were in-
dependently associated with postoperative MV dysfunction
(no use of an annuloplasty ring: HR, 1.19; 95% CI, 0.44–
3.19; P ¼ .773; papillary muscle–splitting technique: HR,
2.15; 95% CI, 0.86–5.39; P ¼ .102). Rheumatic MVgery c May 2010
FIGURE 1. Freedom from postoperative mitral valve (postop. MV) dis-
ease. Overall postoperative MV disease–free rates were 84.1%  2.7%
at 3 years and 79.0%  3.4% at 5 years.
FIGURE 2. Freedom from atrial fibrillation (AF) without amiodarone
(AMD). In the control group AF-free rates were 91.1%  2.3% at 3 years
and 85.9%  3.4% at 5 years. In the disease group they were 81.1% 
6.9% at 3 years and 65.2%  10.3% at 5 years.
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(HR, 1.39; 95% CI, 0.62–3.09; P ¼ .416).Rhythm Outcomes and Antiarrhythmic Medication
Thirty-seven (17.9%) patients experienced early AF
events (29 in the control group and 8 in the disease group,
P ¼ .468). Twenty-eight patients experienced late (>3
months) recurrence of AF during follow-up (18 in the con-
trol group and 10 in the disease group). Of them, 20 received
amiodarone, which resulted in sinus rhythm conversion in
all. Of those 20 patients, 11 re-experienced AF recurrence
after discontinuation of amiodarone and were restarted on
the medication subsequently. Of 8 individuals who were
not treated with amiodarone, 2 regained sinus rhythm by
means of electrical cardioversion, and 6 were left untreated
for AF because they were single episodes detected by means
of Holter monitoring without symptoms. None of the pa-
tients who experienced late AF recurrence progressed to per-
sistent AF. Another 34 patients had been taking amiodarone
from the early postoperative period, and the treatment was
eventually discontinued without any episode of late AF re-
currence. The overall AF-free rates without antiarrhythmic
medication were 89.2%  2.3% at 3 years, 82.0% 
3.5% at 5 years, and 75.5%  5.4% at 8 years. Late AF re-
currence was more frequent in the disease group than in the
control group (P ¼ .014, Figure 2).
Univariate risk factor analysis for other variables revealed
that a larger preoperative LA size (>60 mm, P ¼ .045) and
the presence of an early postoperative AF event (P ¼ .008)
were factors associated with late AF recurrence. Cox multi-
variate analysis revealed that a larger preoperative LA size,
the use of microwave ablation rather than cryoablation, and
the presence of an early postoperative AF event or postoper-The Journal of Thoracic and Carative MV disease were independent factors associated with
AF recurrence (Table 3).Postoperative LA Size and Transmitral A-Wave
Assessments
LA size decreased immediately after the operation, from
60.1  9.7 mm to 46.6  6.7 mm (P< .001), without an
intergroup difference (P ¼ .204). LA size was larger in the
disease group than in the control group over the 6-month
to 3-year period (Figure 3).
The transmitral A-wave prevalence of patients in normal
sinus rhythm was 74.5% to 95.4%. In between-group com-
parisons differences were found over a postoperative 2- to
3-year period (Figure 4, A). There were no significant differ-
ences in transmitral A-wave velocity between groups at each
postoperative time point up to 4 years (Figure 4, B).DISCUSSION
The present study investigated the association between
postoperative mitral valvulopathy after mitral repair and
maze procedure outcomes. The study found that postopera-
tive mitral valvulopathy was associated with a greater risk of
AF recurrence and patients who showed early AF events had
more incidence of late AF recurrence than those who did not.
The Cox maze procedure is the most effective surgical
procedure for treating AF and its adverse consequences of
irregular rhythm, altered hemodynamics, and increased
thromboembolic risk.2,10-12 Although the procedure is very
effective, it does not resolve AF in all patients.3,5,6,10,11 A
number of studies have reported that of patients who re-
gained sinus rhythm after the maze procedure, some experi-
enced late recurrence of AF, which limits the benefit of thediovascular Surgery c Volume 139, Number 5 1173
TABLE 3. Univariate and multivariate analyses of AF recurrence
Univariate analysis Multivariate analysis
P value HR 95% CI P value
Preoperative factors
Age>60 y .706
Presence of
coronary disease
.814
Ejection fraction
<50%
.455
Left atrial size
>60 mm
.028* 2.61 1.04–6.52 .041*
Cardiothoracic ratio
>60%
.715
Fine AF-wave
pattern
.134 2.00 0.92–4.34 .079
Persistent vs
paroxysmal AF
.271
AF duration>5 y .435
Rheumatic vs
degenerative
.401
Preoperative MR vs
MS
.513
Operative factors
Mitral ring
annuloplasty
.175
Microwave ablation
vs cryoablation
.080 2.33 1.03–5.23 .041*
Minimally invasive
approach
.058
Postoperative factors
Postoperative MV
dysfunction
.014* 3.67 1.48–9.08 .005*
Presence of early
AF event
.003* 3.75 1.65–8.52 .002*
HR, Hazard ratio; CI, confidence interval; AF, atrial fibrillation; MR, mitral regurgita-
tion; MS, mitral stenosis; MV, mitral valve. *P< .05.
FIGURE 3. Postoperative changes in left atrial dimension (in millimeters).
Left atrial size was significantly larger in the disease group than in the con-
trol group over a 6-month to 3-year period.
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Dprocedure. The risk factors for late recurrence of AF after the
maze procedure include patient age, longer preoperative AF
duration, fine AF-wave pattern, and increased LA size.3,5,6
Long-term pressure and volume overload on the LA wall
caused by MV disease induces LA tissue stretching and fi-
brosis and resultant LA wall thinning and enlargement.3
These changes in LA tissue increase susceptibility to AF de-
velopment. As a result, AF is observed in 40% to 60% of
patients who require MV surgery.1 Considering the preoper-
ative pathogenesis, it can be speculated that postoperative
remnant or recurrent MV disease is likely to increase the
risk of AF recurrence. Although previous studies that ana-
lyzed AF recurrence after the maze procedure mainly
investigated which preoperative factor might affect AF
recurrence,3,5,6 the present study is the first to examine the
association between postoperative mitral valvulopathy and
rhythm outcomes. Univariate and multivariate analyses con-
firmed the association between postoperative mitral dys-
function and late AF recurrence, and the sequentiality of1174 The Journal of Thoracic and Cardiovascular Surevents was in the order of AF recurrence following the
MV dysfunction. These results strongly suggest that postop-
erative MV dysfunction negatively affects the rhythm out-
comes after the combination of MV repair and the maze
procedure.
In the present study LA size was significantly larger in the
disease group than in the control group in most postoperative
periods. However, postoperative LA size was about 47 to 50
mm in the disease group, and intergroup discrepancy in LA
size was about 4 mm, which is not similar to the degree of
LA enlargement seen in patients with MV disease who
have AF in general. This relatively small between-group dif-
ference in LA size might be explained by LA wall resection
performed during the maze procedure. With the same
amount of volume and pressure load, the effect of LA en-
largement is expected to be reduced if the LA wall mass is
reduced.
The present study revealed that patients who had early
AF events had more than 3 times the incidence of late AF
recurrence than those who did not (HR, 3.75). It seems to
be a significant finding that the rhythm status in the early
postoperative period has a strong predictive value in the
long-term rhythm outcome after the maze procedure. This
finding suggests that patients who have early AF events
should not be regarded as they are in a transient state in
the postablation blank period but should be carefully mon-
itored for late AF recurrence in the long-term.
Since the introduction of standardized techniques for MV
reconstruction, MV repair has become the surgical treatment
of choice for MR.13 Although repair durability is acceptable
for most patients, some require late reoperation for recurrent
MV dysfunction.14-18 A study evaluated MR recurrences us-
ing echocardiographic follow-up after mitral repair and
found that freedom from recurrence of nontrivial MR was
58.6% at 5 years and only 27.2% at 7 years.14 In that study
the linearized recurrence rate of MR of greater than grade 1
was 6.9% per year, and that of MR of greater than grade 2gery c May 2010
FIGURE 4. Transmitral A-wave prevalence (A) and velocity (B). Beyond
the immediate postoperative period, A-wave prevalence was maintained at
greater than 80% up to 4 years. In intergroup comparisons the differences
were found over a 2- to 3-year period, with a lower A-wave prevalence in
the disease group. There were no significant differences in transmitral
A-wave velocity between groups throughout the postoperative period.
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sion of the degenerative process over time. In the present
study the presence of postoperative MV disease was defined
by using echocardiographic data and was presented as
a time-related event to precisely delineate the relationship
between postoperative MV dysfunction and AF recurrence.
Of the 39 patients who had postoperative MV disease, the
disease was detected in only 6 before hospital discharge,
whereas it was detected in the remaining 33 patients during
follow-up. If we had defined the risk group according to
the immediate postoperative echocardiographic assessment
only, those patients with late recurrence of MV disease
would have been included in the control group, which in
turn would have created a misinterpretation regarding the re-
lationship between postoperative MV dysfunction and AF
recurrence. The finding that MV dysfunction was mostly
detected after discharge reflects that the recurrence of MV
disease after MV repair is an ongoing process, which is
consistent with a previously reported study.14 The findings
highlight that even when initial echocardiographic assess-
ment indicates successful MV repair, careful long-term
follow-up echocardiographic analysis is required to assessThe Journal of Thoracic and CaranyMV function deterioration. These efforts seem to be nec-
essary not only for the selection of reoperation candidates
but also for predicting AF recurrence, which heightens the
risk of lethal thromboembolic complications.
Another interesting finding in this study is that the use of
microwave ablation resulted in greater AF recurrence com-
pared with cryoablation. Although a number of studies had
reported excellent results with the use of microwave ablation
in AF ablation surgery, those studies have recorded follow-
up rhythm data for only less than 1 year.19-21 This is quite
contrary to cryoablation, for which long-term results have
shown similar results as seen with the conventional cut-
and-sew Cox maze procedure in terms of restoration and
maintenance of sinus rhythm.4,22,23 To our knowledge,
only 1 study has investigated the long-term (>1 year) out-
comes of LA endocardial microwave ablation.24 In that
study, with a mean follow-up duration of 5.37 0.91 years,
only 39.3% of patients were in sinus rhythm after 5 years.
The authors concluded that microwave ablation is not a reli-
able method for achieving long-term conversion to sinus
rhythm because of a lack of lesion transmurality. In support
of their hypothesis, a postmortem histologic study in which
3 patients underwent microwave ablation for the treatment
of AF showed that in autopsies performed within 22 days
of surgical intervention, the atrial lesions were not transmu-
ral and the extent of myocardial damage was highly
variable.25
The result of the present study also raises a question on the
efficacy of microwave ablation. Because there has been no
study comparing the long-term effect of microwave ablation
and cryoablation, further studies are necessary to verify the
result from the present study.
Limitations
This study is subject to the limitations inherent to retro-
spective observational data studies. Efforts made to over-
come such limitations included prospective data collection
and storage of data in a designed and regimented database.
The purpose of this study was to delineate the influence
of postoperative MV dysfunction on AF recurrence in the
long-term after surgical intervention. Therefore patients
who initially did not have restored sinus rhythm were ex-
cluded from the analyses. This patient selection might
have led to the difference with results from other studies,
which reported the clinical significances of patients’ preop-
erative conditions on the rhythm outcomes after the maze
procedure.
LA size dilatation caused by MV disease is the most im-
portant phenomenon in the pathogenesis of AF develop-
ment. However, AF itself has the effect of LA chamber
enlargement when assessed by means of echocardiography
or other imaging studies. In our study we could not deter-
mine whether an increase in LA size in the disease group
was the result of postoperative MV dysfunction ordiovascular Surgery c Volume 139, Number 5 1175
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sue, patients should be grouped into 4 groups according to
the presence or absence of postoperative MV dysfunction
and AF recurrence, respectively, and LA size should be
compared between the groups. However, there were only
11 patients who showed recurrent AF in the disease group
and only 18 patients in the control group. This sample size
was too small to generate statistical power when serial
changes in LA size were compared between the groups.
Such analysis requires a larger patient population.
The measurement of LA dimension was used in the pres-
ent study; however, LA volume index might be a better in-
dicator of LA size, which takes into account the patient’s
body surface area.
CONCLUSIONS
Postoperative MV dysfunction and early AF events were
found to be independent factors associated with late AF re-
currence after MV repair combined with the maze proce-
dure. Patients with postoperative MV dysfunction had
a greater LA size throughout the postoperative period than
those without MV dysfunction. Any patient with MV dys-
function postoperatively should be closely monitored for
AF recurrence and adequately managed.
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